From: Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma
Adverse events | Grade 1–2 | Grade 3–4 |
---|---|---|
Alopecia | 88.2% (15/17) | |
Neutropenia | 64.7% (11/17) | 17.6% (3/17) |
Fatigue | 52.9% (9/17) | 11.8% (2/17) |
Anemia | 47.1% (8/17) | 11.8% (2/17) |
Nausea | 41.2% (7/17) | 5.9% (1/17) |
Leukopenia | 35.3% (6/17) | 11.8% (2/17) |
Peripheral neuropathy | 29.4% (5/17) | 5.9% (1/17) |
Anorexia | 29.4% (5/17) | |
Diarrhea | 23.5% (4/17) | 5.9% (1/17) |
Thrombocytopenia | 23.5% (4/17) | 5.9% (1/17) |
Alkaline phosphatase increased | 17.6% (3/17) | |
Fever | 11.8% (2/17) | |
Abdominal pain | 11.8% (2/17) | |
Pneumonitis | 5.9% (1/17) |